Liquan Huang | Signal Transduction Mechanisms | Best Researcher Award

Posted on by sciencefather

Prof. Dr. Liquan Huang | Signal Transduction Mechanisms | Best Researcher Award

Prof. Dr. Liquan Huang , Zhejiang University – Zijingang Campus , China

Liquan Huang is a distinguished molecular biologist specializing in taste transduction and chemosensory research. He completed his Ph.D. in Molecular Biology from Yale University in 1996 under Dr. Michael Lerner and pursued postdoctoral training at Mount Sinai School of Medicine, New York University. With extensive experience in molecular physiology, Dr. Huang has made significant contributions to sensory perception and signaling pathways. Currently, he serves at Zhejiang University, China, where he leads groundbreaking research on G-protein signaling and taste receptor mechanisms. His work has been widely published in top-tier journals, influencing the fields of neuroscience and molecular biology. Dr. Huang has mentored several postdoctoral researchers and contributed to organizing international scientific conferences. His research on sensory transduction has broad applications, including food sciences and human health. His dedication to advancing scientific knowledge makes him a strong candidate for the Best Researcher Award.

Publication Profile:

Orcid

Strengths for the Award:

  1. Extensive Research Contributions – Dr. Liquan Huang has an impressive publication record in high-impact journals such as Nature Neuroscience, Journal of Neuroscience, eLife, and PLoS Genetics. His work spans molecular biology, neurophysiology, taste receptor studies, and virology, showing a broad impact in multiple scientific disciplines.

  2. Significant Scientific Impact – His research on taste receptors, G-protein signaling, and environmental viromes has contributed significantly to the understanding of molecular signaling pathways, sensory biology, and viral ecology. His discoveries, such as the pseudogenization of sweet receptors in cats and the role of Gγ13 in inflammation resolution, have broad implications.

  3. Funding and Recognitions – Dr. Huang has received multiple fellowships and research grants, including the Morley R. Kare Fellowship and Small Research Grant Program Award, demonstrating sustained recognition and funding for his work.

  4. Mentorship and Training – Having trained multiple postdoctoral fellows and graduate students, he has contributed to the scientific community by fostering new talent in molecular biology and neuroscience.

  5. International Collaborations and Professional Affiliations – As a member of esteemed organizations like the New York Academy of Sciences, Association for Chemoreception Sciences, and Society for Neuroscience, and as an organizer of major scientific meetings, he has actively contributed to the global research community.

  6. Recent Cutting-Edge Research – His recent work on environmental viromes, the evolution of human pathogenic RNA viruses, and G-protein-mediated inflammation resolution shows his ability to evolve with emerging research trends.

Areas for Improvement:

  1. Diversity of Funding Sources – While Dr. Huang has received multiple research grants, expanding his funding from diverse international sources and large-scale collaborative grants could further support high-impact research.

  2. Broader Public Engagement – Increased engagement in public science communication, industry collaborations, and policy-making could enhance his influence beyond academia.

  3. Interdisciplinary Expansion – While his research is already multidisciplinary, extending collaborations into areas such as AI-driven bioinformatics, synthetic biology, or applied therapeutics could amplify the translational impact of his work.

Education:

Dr. Liquan Huang has a strong academic background in biology and molecular sciences. He obtained his Ph.D. in Molecular Biology from Yale University in 1996, where he was mentored by Dr. Michael Lerner. Prior to this, he earned an M.Ph. in Biology from Yale University in 1993. His foundational training in cell biology and anatomy began at New York Medical College in 1991. These rigorous academic pursuits equipped him with expertise in molecular and cellular mechanisms, particularly in sensory and chemosensory research. His education laid the groundwork for his later advancements in taste receptor studies and G-protein signaling pathways. His tenure at these prestigious institutions provided him with a strong theoretical and experimental foundation, allowing him to excel in interdisciplinary research. His academic excellence was further recognized through fellowships at Yale University and New York Medical College, highlighting his commitment to scientific innovation.

Experience:

Dr. Liquan Huang has an extensive research and academic career spanning over three decades. He began his career as an Assistant Researcher at the Institute of Genetics, Academia Sinica, China (1987–1990). Following his doctoral studies, he pursued postdoctoral research at Mount Sinai School of Medicine, New York University (1996–2000) under Dr. Robert F. Margolskee. He later became an Instructor in the Department of Physiology and Biophysics at Mount Sinai School of Medicine (2000–2002). Currently, he is a researcher and faculty member at Zhejiang University, leading studies in molecular physiology and taste transduction. Dr. Huang has also trained multiple postdoctoral fellows and collaborated on high-impact research. His expertise in sensory biology has led to numerous publications and organizing roles in international conferences. His contributions to neuroscience, molecular biology, and sensory perception establish him as a leading figure in the field.

Awards and Honors:

🏅 Morley R. Kare Fellowship (2004–2006) – Recognized for excellence in chemosensory research.
🎖 Small Research Grant Program Award (R03 DC05154) (2002–2005) – Supported research on molecular taste mechanisms.
🏆 Individual National Research Service Award (F32DC00310) (1998–2000) – Awarded for outstanding postdoctoral research contributions.
🥇 Institutional National Research Service Award (T32DA07135) (1997–1998) – Recognized for research excellence in molecular biology.
🎓 Yale University Fellowship (1991–1996) – Prestigious scholarship for Ph.D. studies in Molecular Biology.
🎖 New York Medical College Fellowship (1991) – Awarded for academic excellence in cell biology training.

Research Focus:

🔬 Taste Transduction & Chemosensory Signaling – Investigating molecular mechanisms of taste receptor activation.
🧬 G-Protein Signaling Pathways – Studying Gγ13 subunit’s role in sensory processing and inflammation resolution.
🦠 Virology & Environmental Microbiology – Exploring deep-sea RNA viromes and their evolutionary significance.
🩺 Biomedical Applications – Examining taste receptor implications in human health and disease.
🍽 Food Science & Peptidomics – Identifying bioactive peptides with taste-modulating properties.

Publications Top Notes📚:

1️⃣ Gγ13 colocalizes with gustducin in taste receptor cells – Nature Neuroscience 🧠
2️⃣ Tas1r3 encodes a new taste receptor – Nature Genetics 🧬
3️⃣ Transient receptor potential channel in taste receptor cells – Nature Neuroscience ⚡
4️⃣ G protein subunit G13 in retinal ON bipolar cells – Journal of Comparative Neurology 👁
5️⃣ Polymorphisms in Tas1r3 gene affect saccharin preference – Journal of Neuroscience 🧪
6️⃣ Cats’ indifference toward sugar due to receptor pseudogenization – PLoS Genetics 🐱
7️⃣ Voltage-gated chloride channel in taste bud cells – Journal of Biological Chemistry 🌊
8️⃣ Human taste: peripheral anatomy & transduction – Advances in Otorhinolaryngology 👅
9️⃣ Interferon pathways activated in taste bud cells – Journal of Neuroscience 🦠
🔟 Bitter peptides activate human bitter receptors – Biochemical and Biophysical Research Communications 🍵

Conclusion:

Dr. Liquan Huang’s extensive contributions to molecular biology, neuroscience, and virology, combined with his mentorship, international collaborations, and leadership in scientific meetings, make him a strong candidate for the Best Researcher Award. While there is always room for growth in funding diversification and interdisciplinary expansion, his body of work demonstrates excellence and innovation in his field.

Ranran Li | Signal Transduction Mechanisms | Best Researcher Award

Posted on by sciencefather

Dr. Ranran Li | Signal Transduction Mechanisms | Best Researcher Award

Ranran Li , Ruijin Hospital, Shanghai Jiao Tong University School of Medicine , China

Dr. Ranran Li is an associate researcher at Ruijin Hospital, Shanghai Jiao Tong University School of Medicine in Shanghai, China. She earned her Ph.D. from the University Medical Center of Groningen, Netherlands, in 2015, before returning to Shanghai to focus on critical care medicine. Her research centers on sepsis-associated endothelial dysfunction and its underlying molecular mechanisms. Over the years, Dr. Li’s work has provided valuable insights into the role of metabolic disorders and post-translational modifications in regulating endothelial inflammation and coagulation during sepsis. She has published extensively in reputable journals and holds several patents. Her recent findings suggest potential therapeutic targets for the treatment of sepsis and related complications, including endothelial dysfunction and organ injury.

Publication Profile:

Scopus

Strengths for the Award:

Dr. Ranran Li is a distinguished researcher with notable expertise in the mechanisms of sepsis-associated endothelial dysfunction. Her work in identifying the role of metabolic disorders and post-translational modifications in sepsis has been pivotal in advancing the understanding of vascular inflammation and coagulation during critical illness. Her research has led to several high-impact publications and patents, showcasing her contributions to the field. Furthermore, Dr. Li’s interdisciplinary approach, combining metabolic biology, cell signaling, and translational medicine, has provided valuable therapeutic targets for the treatment of sepsis and endothelial dysfunction. Her collaborations with international experts enhance her work’s impact and broaden the scope of her research.

Areas for Improvements:

While Dr. Li’s research has been extensive and groundbreaking, future improvements could include increased collaborations with industry partners to accelerate the translation of her findings into clinical therapies. Expanding her professional network through international collaborations in other areas of critical care medicine could also provide new perspectives and avenues for innovation. Additionally, engaging in larger-scale clinical studies might help further validate her findings in human models.

Education

Dr. Ranran Li obtained her Ph.D. in Medical Sciences from the University Medical Center of Groningen, Netherlands, from 2011 to 2015. During her doctoral studies, she focused on the molecular mechanisms of sepsis and its impact on vascular endothelial dysfunction. Her Ph.D. research laid the foundation for her ongoing investigations into the pathophysiology of sepsis and endothelial injury. Following her Ph.D., she joined Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, in 2016 as an associate researcher in the Department of Critical Care Medicine. Here, Dr. Li furthered her research into sepsis, vascular inflammation, and metabolic disorders. She has developed an expertise in endothelial dysfunction and coagulation, specifically in the context of sepsis-induced organ injuries. Dr. Li’s comprehensive academic training, both in Europe and China, has significantly contributed to her innovative research work and international collaborations.

Experience:

Dr. Ranran Li has been serving as an associate researcher at Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, since 2016. Prior to this, she earned her Ph.D. from the University Medical Center of Groningen in the Netherlands, where she focused on sepsis and endothelial dysfunction. In her current position, Dr. Li has worked extensively on understanding the mechanisms underlying sepsis-associated endothelial dysfunction, with a particular focus on metabolic disorders and post-translational modifications. Her work has provided critical insights into the role of fatty acid metabolism, insulin resistance, and histone modifications in regulating endothelial inflammation and coagulation activation in sepsis. Dr. Li’s research has led to multiple publications in high-impact journals and the filing of patents for innovative therapeutic approaches. She collaborates with leading researchers in the Netherlands and has contributed significantly to the understanding of vascular injury and its therapeutic targets in sepsis.

Research Focus:

Dr. Ranran Li’s research focuses on the molecular mechanisms of sepsis-associated endothelial dysfunction, with a particular emphasis on metabolic disorders and post-translational modifications. She has been exploring how fatty acid metabolism, glucose-lipid metabolism, and protein acetylation influence endothelial cells during sepsis, leading to organ injury. Her research has highlighted the role of metabolic shifts, including the activation of pathways like AMPK/PKA, in endothelial inflammation and coagulation activation. Dr. Li has also studied the role of histone modifications, including lactylation, in promoting endothelial ferroptosis and dysfunction during sepsis-induced lung injury. She has been pioneering the exploration of metabolic signaling pathways and their potential as therapeutic targets for managing sepsis-related endothelial damage. Her work aims to identify novel strategies to prevent or mitigate vascular injury in septic patients. Dr. Li’s findings have led to both patents and high-impact publications in critical care and translational medicine.

Publications Top Notes:

  1. Shiyuan He et al., Fatty acid synthesis promotes mtDNA release via ETS1-mediated oligomerization of VDAC1 facilitating endothelial dysfunction in sepsis-induced lung injury 🧬🫁 Cell Death and Differentiation, 2025
  2. Ranran Li et al., ATP-citrate lyase controls endothelial gluco-lipogenic metabolism and vascular inflammation in sepsis-associated organ injury 💉🧪 Cell Death and Disease, 2023
  3. Jie Liu et al., Designed microchannel-based lipid nanoparticles encapsulated siRNA targeting gasdermin D for sepsis management via pulmonary delivery 🧬💉 Nano Today, 2025
  4. Fangchen Gong et al., H3K14la drives endothelial dysfunction in sepsis-induced ARDS by promoting SLC40A1/transferrin-mediated ferroptosis 🧬🔥 MedComm, 2025
  5. Jiayin Cui et al., Herbal-based Xuebijing injection ameliorated vascular endothelial dysfunction via inhibiting ACLY/MYB/RIG-I axis in sepsis-associated lung injury 🌱💊 Phytomedicine, 2025
  6. Shasha Lu et al., GDF15 ameliorates sepsis-induced lung injury via AMPK-mediated inhibition of glycolysis in alveolar macrophage 💨🧪 Respiratory Research, 2024
  7. Rui Tian et al., Shenfu injection ameliorates endotoxemia-associated endothelial dysfunction and organ injury via inhibiting PI3K/Akt-mediated glycolysis 💉🫀 Journal of Ethnopharmacology, 2024
  8. Yupeng Zhao et al., H3K18 lactylation-mediated VCAM1 expression promotes gastric cancer progression and metastasis via AKT-mTOR-CXCL1 axis 🎗️🧬 Biochemical Pharmacology, 2024
  9. Rui Tian et al., Metformin ameliorates endotoxemia-induced endothelial pro-inflammatory responses via AMPK-dependent mediation of HDAC5 and KLF2 💊💉 BBA-Molecular basis of disease, 2019
  10. Lei Pei et al., MSCs-derived extracellular vesicles alleviate sepsis-associated liver dysfunction by inhibiting macrophage glycolysis-mediated inflammatory response 🧬🩸 International Immunopharmacology, 2024

Conclusion:

Dr. Ranran Li is highly deserving of the Best Researcher Award due to her outstanding contributions to understanding the molecular mechanisms underlying sepsis-related endothelial dysfunction. Her innovative research has not only provided deep insights into the pathophysiology of sepsis but has also uncovered potential therapeutic targets for treating this devastating condition. Her exceptional track record of high-quality publications, patents, and collaborative research, combined with her dedication to advancing critical care medicine, makes her an excellent candidate for this prestigious award.